Form 4: Guardant Health Director, Meghan V. Joyce, Reports Stock Transactions

Director Meghan V. Joyce reports the vesting and acquisition of common stock through restricted stock units.

Summary

• On April 4, 2025, Meghan V. Joyce, a director of Guardant Health, Inc., reported a transaction involving common stock.
• The transaction involved the vesting of restricted stock units (RSUs) and the acquisition of 66 shares of common stock.
• Following the transaction, Joyce directly owns 7,780 shares of Guardant Health common stock.
• The RSUs vested according to a schedule that began on August 4, 2022, with 25% vesting initially and the remaining 75% vesting in monthly installments over three years.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for directors and officers of publicly traded companies. It provides transparency to investors regarding the trading activities of company insiders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider trading activity.

Key Dates

Keywords

Guardant Health, Director, Stock Transaction, Form 4, Restricted Stock Units, Common Stock, Beneficial Ownership, Joyce, Meghan V. Joyce